Boston Scientific has acquired Labcoat Limited, a privately held, development-stage drug-eluting stent (DES) developer based in Galway, Ireland. Terms of the acquisition were not disclosed.

Residents of Massachusetts can now compare the cost and quality of care at different hospitals as part of a state plan to put more information in the hands of consumers and thereby control healthcare costs.

The use of advanced visualization software enables the utilization of coronary CT angiography (CCTA) to accurately depict stent fractures in patients that are not clearly depicted by conventional angiography, according to a study published in the December issue of Radiology.

The use of advanced visualization software enables the utilization of coronary CT angiography (CCTA) to accurately depict stent fractures in patients that are not clearly depicted by conventional angiography, according to a study published in the December issue of Radiology.

Virtual Radiologic Corp. (VRC), a global provider of teleradiology services, has entered into a technology partnership with Pro-Laudo, a Brazil-based teleradiology provider.

Lake Charles Memorial Hospital in Lake Charles, La., has begun transitioning its business and clinical information systems with the help of McKesson Provider Technologies in a three-year process at an estimated cost of $6 million.

Medtronic has been successful in its bid, through an indirect wholly-owned subsidiary, to acquire CryoCath Technologies at $8.75 Cdn per share under its previously announced offer dated October 3, 2008.

NEW ORLEANSDrug-eluting stents (DES) are associated with decreased rates of death, MI and revascularization, compared to bare-metal stents (BMS) in a diabetic population, according to results from the MASS-DAC Registry presented Monday during the late breaking clinical trials at the American Heart Association (AHA) Scientific Sessions, and simultaneously published in Circulation.